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Abstract
In vertebrates, oocytes undergo maturation, arrest in metaphase II, and can then be fertilized by sperm. Fertilization initiates molecular
events that lead to the activation of early embryonic development. In Caenorhabditis elegans, where no delay between oocyte maturation
and fertilization is apparent, oocyte maturation and fertilization must be tightly coordinated. It is not clear what coordinates the transition
from an oocyte to an embryo in C. elegans, but regulated turnover of oocyte-specific proteins contributes to the process. We describe here
a gain-of-function mutation (zu405) in a gene that is essential for oocyte maturation, oma-1. In wild type animals, OMA-1 protein is
expressed at a high level exclusively in oocytes and newly fertilized embryos and is degraded rapidly after the first mitotic division. The
zu405 mutation results in improper degradation of the OMA-1 protein in embryos. In oma-1(zu405) embryos, the C blastomere is
transformed to the EMS blastomere fate, resulting in embryonic lethality. We show that degradation of several maternally supplied cell fate
determinants, including SKN-1, PIE-1, MEX-3, and MEX-5, is delayed in oma-1(zu405) mutant embryos. In wild type embryos, SKN-1
functions in EMS for EMS blastomere fate specification. A decreased level of maternal SKN-1 protein in the C blastomere relative to EMS
is believed to be responsible for this cell expressing the C, instead of the EMS, fate. Delayed degradation of maternal SKN-1 protein in
oma-1(zu405) embryos and resultant elevated levels in C blastomere is likely responsible for the observed C-to-EMS blastomere fate
transformation. These observations suggest that oma-1, in addition to its role in oocyte maturation, contributes to early embryonic
development by regulating the temporal degradation of maternal proteins in early C. elegans embryos.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
In Caenorhabditis elegans, blastomeres become commit-
ted to distinct developmental fates very early during em-
bryogenesis. Following the first embryonic division, for
example, the posterior and anterior blastomeres have al-
ready committed to different lineage patterns and tissue
types. The posterior blastomere, P1, is the germline precur-
sor and divides in a stem cell-like pattern, giving rise to a
germline precursor and a somatic sister at each division (see
Fig. 1). The anterior blastomere, AB, divides symmetrically
and produces tissues with distinct fates. After a sequence of
five asymmetric divisions in early embryos, six embryonic
founder cells are born that have distinct lineage patterns and
tissue types.
Factors required for proper development of early C.
elegans embryos are provided maternally and prepackaged
in oocytes. Many maternal proteins important for cell fate
determination have distinct spatial and temporal localization
patterns (Bowerman et al., 1993; Mello et al., 1996). The
combinatorial expression of these maternal factors in early
blastomeres plays a key role in the commitment of blas-
tomeres to distinct patterns of differentiation during the
rapid cell divisions characteristic of early embryogenesis
(see reviews by Bowerman, 2000; Rose and Kemphues,
1998). The inappropriate localization of these maternal pro-
teins results in cell fate transformations of particular early
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blastomeres (Bowerman et al., 1993; Guedes and Priess,
1997; Hunter and Kenyon, 1996; Schubert et al., 2000).
Mechanisms regulating asymmetric distribution of key
regulators have been well characterized in several model
systems. For example, in Drosophila neuroblasts, the ho-
meodomain protein Prospero is targeted to a crescent in the
basal cortex of the dividing neuroblast and is therefore
asymmetrically inherited by the basal daughter (Hirata et
al., 1995; Knoblich et al., 1995). In contrast, the asymmetric
localization of the budding yeast Ash1p protein is a result of
asymmetric localization of its mRNA to the daughter cell
(Bertrand et al., 1998; Long et al., 1997; Takizawa et al.,
1997). A recent study has shown that, in mollusc embryos,
several mRNAs are asymmetrically segregated to daughter
cells by localizing to particular centrosomes prior to divi-
sion (Lambert and Nagy, 2002). In C. elegans, although
most maternal regulatory proteins are asymmetrically local-
ized in early embryos, the majority of these proteins are
supplied as mRNA, and most of these mRNAs are evenly
distributed throughout all early embryonic cells (Seydoux
and Fire, 1994). RNA localization is therefore unlikely to be
the major mechanism for the regulation of asymmetric pro-
tein localization in early C. elegans embryos. At least two
maternal proteins, GLP-1 and PAL-1, are regulated by
asymmetric translation of mRNA in the daughter cells fol-
lowing a division (Evans et al., 1994; Hunter and Kenyon,
1996). Protein degradation can also regulate asymmetric
distribution of maternal regulators and asymmetric cell fates
in C. elegans. Reese et al. (2000) showed that the PIE-1
protein is asymmetrically localized to the germline lineage
through two distinct mechanisms: asymmetric enrichment
of the PIE-1 protein to that side of the cell destined to
become a germline precursor after cell division, and selec-
tive degradation of the PIE-1 protein in the somatic sister
cells. These two mechanisms underlying asymmetric PIE-1
localization are mediated by distinct domains within the
PIE-1 protein. PIE-1 belongs to a family of proteins that
contain two TIS11-like (CCCH) zinc fingers (Mello et al.,
1996). The first zinc finger is necessary and sufficient to
direct PIE-1 protein degradation in the somatic blastomeres
(Reese et al., 2000).
In addition to PIE-1, several other TIS11 zinc finger-
containing proteins have been shown genetically to function
in the specification of early blastomere fate (Guedes and
Priess, 1997; Schubert et al., 2000; Tabara et al., 1999).
MEX-1 and POS-1, like PIE-1, are also germline-specific
proteins. Like PIE-1, the germline-specific distribution pat-
tern of these two proteins also relies on first zinc finger-
based selective degradation in somatic sister cells (Reese et
al., 2000). Two other TIS11 zinc finger proteins, MEX-5
and MEX-6, are nearly identical proteins with redundant
functions during embryogenesis (Schubert et al., 2000). The
spatial distribution pattern of MEX-5 is complementary to
that of PIE-1, MEX-1, and POS-1, being detected only in
somatic sisters and not germline precursors (Schubert et al.,
2000). The mechanism that regulates the distribution pattern
of MEX-5 has not been determined.
OMA-1 and OMA-2 are also closely related TIS11 finger
proteins with redundant biological function during C. el-
egans development (Detwiler et al., 2001). They are unique
compared with other TIS11 finger proteins characterized so
far in that they play an essential role in the development of
the C. elegans germline, specifically in oocyte maturation
(Detwiler et al., 2001). We have shown previously that both
OMA-1 and OMA-2 express in developing oocytes, peak-
ing in the maturing oocyte. Both OMA-1 and OMA-2 pro-
teins were also detected in newly fertilized embryos, but it
was not known whether their functions are required in
embryo development as oma-1; oma-2 mutant animals are
sterile (Detwiler et al., 2001).
We describe here the very unique temporal distribution
of OMA-1 protein in early C. elegans embryos and an
embryonic lethal phenotype resulting from inappropriate
degradation of the OMA-1 protein. Using a GFP fusion, we
show that the level of OMA- 1 protein remains high in
wild-type fertilized zygotes but is rapidly degraded imme-
diately after the first mitotic division. This degradation is
important for embryonic development as a gain-of-function
mutation zu405 that results in a defect in the proper degra-
dation of OMA-1 protein results in embryonic lethality. In
zu405 mutant embryos, the C blastomere adopts the fate of
the EMS blastomere. We show further that the C-to-EMS
fate transformation is likely a result of delayed degradation
of the maternal transcription factor, SKN-1. The degrada-
tion of several other maternal proteins, including PIE-1,
POS-1, MEX-1, MEX-3, and MEX-5, is also delayed in
zu405 embryos. These results suggest that correct temporal
regulation of OMA-1 protein degradation is critical for
proper embryo development. Furthermore, our data suggest
an intriguing model whereby the OMA-1 protein functions,
in addition to in oocyte maturation, in early embryos to
Fig. 1. Schematic diagrams of early embryos and cleavages of C. elegans
embryos. Horizontal lines on the lineage diagram represent cell divisions.
The branch of the lineage that produces germline precursors is indicated by
thick black line. Names of blastomeres mentioned in the text are listed. In
the embryo diagram, germline blastomeres are outline in thick black lines
and their corresponding somatic sisters are shown shaded. Anterior is to the
left and dorsal is up.
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regulate the correct temporal degradation of a subset of
maternal factors.
Materials and methods
Strains
The N2 Bristol strain was used as the wild-type strain.
The genetic markers used were: LGIV: eDf18, fem-
3(e1950), unc-129(ev554), oma-1(zu405). All strains were
cultured as described by Brenner (1974). Transgenic strains
containing Pmed-1gfp (JR1186) or Ppie-1gfp were provided
by Joel Rothman (Maduro et al., 2001) and Geraldine Sey-
doux (Reese et al., 2000), respectively.
Genetics and rescue of oma-1(zu405)
Homozygous oma-1(zu405) worms grown at 15°C have
a low percentage (1–2%) of animals exhibiting defects in
the posterior portion of the body. In these worms, the tail
fails to undergo proper morphogenesis and often form a
nob-like structure. We mapped the zu405 mutation to chro-
mosome IV and showed that the zu405 locus is deleted in
the deficiency eDf18. Hermaphrodites heterozygous for the
deficiency eDf18 produce approximately 25% of dead em-
bryos, suggesting that the amount of dead embryos ob-
served with zu405/ hermaphrodites were not due to hap-
loid insufficiency. Three-factor mapping places zu405
approximately 0.04 map units to the left of the cloned gene
fem-3 and very close to unc-129. We have assayed cosmids
surrounding the genomic region where the unc-129 gene
resides for their ability to rescue the embryonic lethality
associated with zu405. Injection was performed by using the
complex array method as described in Kelly et al (1997).
Injected worms were cultured at 15°C until F2. For each
transgenic line, F2 transgenic animals were shifted to 25°C
at L4, and the viability of F3 progeny was scored. While all
other cosmids assayed produced no viable F3 progeny, F2
animals containing the cosmid C27B7 or C09G9 gave ap-
proximately 3–5 viable larvae, suggesting weak rescue. The
rescuing activity was further narrowed down by injecting
PCR amplified fragments covering the genomic region of
overlap between these two cosmids. When a 6-kb region
that contains only two transcription units, C27B7.1 and
C09G9.6, was injected, we obtained a higher number of
viable F3 larvae, up to approximately 30 progeny from 1
transgenic line. Depleting either of these two genes in wild
type embryos by RNAi failed to reveal a phenotype. How-
ever, depleting C09G9.6, but not C27B7.1, in zu405 mutant
worms rescued the embryonic lethality at 25°C.
Generation of OMA-1-GFP-expressing strain
The Poma-1gfp plasmid was constructed as follows: the
6-kb rescuing genomic sequence containing the entire
OMA-1 coding sequence, 2.1 kb upstream, and 2.7 kb
downstream coding sequences was cloned into the Blue-
script pSK. An SfiI site was engineered by site directed
mutagenesis at the last nucleotide of oma-1 coding region
(pRL472). The gfp sequence was PCR amplified from
pPD104.53 with primers each containing an SfiI site and
subcloned into the SfiI site of pRL472 resulting in pRL475.
Transgenic animals expressing OMA-1::GFP (TX189) were
generated by microparticle bombardment according to the
protocol by Praitis et al. (2001). TX189 segregates 100%
transgenic animals, consistent with it being an integrated
line (teIs1).
Analysis of embryos and imaging
Light microscopy was performed with a Zeiss Axioskop
II or an Axioplan II microscope equipped with epifluores-
cence, polarizing, and differential interference contrast
(DIC) optics. Digital images were acquired and processed
either with a C5985 chilled CCD camera (Hamamatsu Pho-
tonics) or with a MicroMax-512EBFT CCD camera
(Princeton Instruments). Embryos were processed for light
microscopy following the procedure of Sulston et al. (1983)
and for immunofluorescence as described in Lin et al.
(1998). Intestinal cells were identified by their birefringent
gut-specific granules and by staining with the monoclonal
antibody MabICB4 (Kemphues et al., 1988). Pharyngeal
cells were assayed by staining with Mab3NB12, a mono-
clonal antibody recognizing a subset of pharyngeal muscles
(Priess and Thomson, 1987). Laser ablations were per-
formed at 25°C by using a VSL337 laser power (Laser
Science) attached to a Zeiss Axioskop microscope as de-
scribed in Avery and Horvitz (1989). After laser operation,
embryos were incubated at 25°C for 12 h and examined
under the light microscope and by immunofluorescence
microscopy following antibody staining.
In situations where the GFP expression was monitored in
live embryos, GFP and DIC images were collected with the
MicroMax-512EBFT CCD camera and processed by using
a custom program EditView4D as previously described
(Rogers et al., 2002). Consecutive time points are 30 s apart.
The raw pixel values were within the linear range of the
CCD camera (0-4095). The 90% reduction of OMA-1::GFP
after the first embryonic division was an estimation based
on the fluorescence intensity on selected focal planes.
Antibody staining
Both wild type and oma-1(zu405) mutant embryos were
prepared for immunofluorescence as follows: worms were
synchronized and cultured at 15°C until L4, shifted to 25°C
for 16 h, and fixed for immunofluorescence at 25°C. Fixa-
tion protocols for OMA-1 (Detwiler et al., 2001), SKN-1
(Lin et al., 1998), MEX-1 (Guedes and Priess, 1997),
MEX-3 (Draper et al., 1996), MEX-5 (Schubert et al.,
2000), and POS- 1 (Tabara et al., 1999) were as described.
Antibody dilutions used were: OMA-1 affinity purified, 1:2;
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SKN-1 monoclonal F2AF4C, no dilution (Bowerman et
al., 1993); MEX-1 affinity purified, 1:5; MEX-3 monoclo-
nal, no dilution; MEX-5 monoclonal, 1:5; POS-1, poly-
clonal 1:200; goat anti-mouse or goat anti-rabbit Alexa488
secondary antibody (Molecular Probes), 1:500.
RNA interference
Double-stranded RNA corresponding to wrm-1 and
skn-1 were derived from clones yk283g8 and pRL803, re-
spectively, and were injected at concentrations of 1–3
mg/ml (Hsu et al., 2000). All injections were performed into
young adults raised at 15°C, then shifted to 25°C after
injection (Hsu et al., 2000). Embryos collected 16 h after
injection were scored for phenotype.
Results
Isolation of the temperature-sensitive, maternal-effect
lethal mutation, zu405
The zu405 mutation was isolated in a screen for temper-
ature-sensitive, maternal- effect, lethal mutations that result
in excess intestinal tissues. Embryos from zu405 homozy-
gous mothers (hereafter zu405 mutant embryos) produce
100% dead embryos at a nonpermissive temperature (25°C,
n  1000) and 30–80% dead embryos at a permissive
temperature (15°C). zu405/ embryos derived from ho-
mozygous zu405 hermaphrodites mated with wild type
males at 25°C do not hatch, indicating that the mutant
phenotype shows strict maternal effect. The temperature-
sensitive lethality of zu405 is semidominant, as zu405/
hermaphrodites generate approximately 80% dead embryos
at 25°C (n  500). At a nonpermissive temperature, em-
bryos from mothers trans-heterozygote for zu405 and the
deficiency eDf18 that removes the zu405 locus appear in-
distinguishable from embryos produced by zu405 homozy-
gous mothers (see Materials and methods).
The zu405 mutation is in the gene oma-1
We positioned the zu405 mutation by classic genetic
mapping and cloned the gene mutated by transformation
rescue (see Materials and methods). The zu405 mutation is
in the gene oma-1, which we have shown to function in C.
elegans oocyte maturation (Detwiler et al., 2002). The
oma-1 gene encodes a protein containing two zinc fingers of
a class first identified in the mouse TIS11 protein and found
in more than 20 proteins in C. elegans (Detwiler et al., 2001;
Guedes and Priess, 1997; Mello et al., 1996; Schubert et al.,
2000; Tabara et al., 1999; Varnum et al., 1989). TIS11 zinc
fingers are found in a small subset of the zinc finger protein
superfamily and consist of C-X8–10-C-X5-C-X3-H, where X
refers to any amino acid (Bai and Tolias, 1996; DuBois et
al., 1990; Varnum et al., 1989). We have shown that null
mutations in oma-1 have no abnormal phenotype but double
loss-of-function mutations in oma-1 and its most closely
related C. elegans gene, oma-2, are sterile with a defect in
oocyte maturation (Detwiler et al., 2002). The zu405 muta-
tion contains a single nucleotide change (C3T) in the
coding region of oma-1, which converts proline 240 to
leucine. Proline 240 is located within the C-terminal domain
of the OMA-1 protein downstream of both TIS-11 zinc
fingers. Depleting oma-1 by RNAi in oma-1(zu405) mutant
worms rescued the embryonic lethality at 25°C, indicating
that zu405 is a gain-of-function mutation (Detwiler et al.,
2002).
OMA-1 protein is detected at high levels in the one-cell
embryo but is then rapidly and asymmetrically degraded
OMA-1 and OMA-2 have redundant functions in oocyte
maturation and have very similar expression patterns. Using
antibodies specific to either OMA-1 or OMA-2, these two
proteins are expressed in the cytoplasm with increasing
levels in growing oocytes, peaking in the oocyte undergoing
maturation (Detwiler et al., 2001). The levels of OMA-1 and
OMA-2 proteins remain very high following fertilization as
well as throughout the first mitotic cycle. The antibody
staining often included a slight punctate pattern of fluores-
cence. Immediately after the first mitotic division, the levels
of OMA-1 and OMA-2 proteins rapidly decreased and be-
came difficult to detect with antibody staining (Fig. 2A, and
data not shown).
The rapid decrease in the level of OMA-1 and OMA-2
after the first mitotic division was intriguing as it distin-
guished these two proteins from all other C. elegans mater-
nal proteins characterized to date. Like mRNAs for most
other maternally supplied regulatory proteins, the mRNA
for oma-2 is detected at a high level in all early blasto-
meres up to at least the four-cell stage (The Nematode
Expression Pattern DataBase, http://nematode.lab.nig.ac.jp/
db/index.html) Therefore, the rapid decrease in OMA pro-
tein levels is likely the result of rapid protein degradation.
To investigate the dynamic regulation of the OMA-1 protein,
we created transgenic animals expressing OMA-1::GFP un-
der the control of its own promoter (see Materials and
methods). The OMA-1::GFP fluorescence in the developing
oocytes and one-cell embryos recapitulated the wild-type
spatial and temporal patterns of OMA-1 antibody staining
(Fig. 2B, and data not shown). The punctate staining ap-
peared more pronounced and resembled the characteristic
pattern of germline P granules. Starting with the onset of the
first mitotic division, the intensity of OMA-1-GFP fluores-
cence rapidly decreased, and by the time the division was
complete, only approximately 10% remained (Fig. 2B).
Interestingly, that remaining 10% of the GFP signal in the
two-cell embryo was predominantly found in the germline
precursor, P1, associated with what appeared to be P gran-
ules (Fig. 2C). The GFP signal continued to decrease in
two-cell embryos and again was asymmetric after the next
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division, with most of the remaining fluorescence segre-
gated to P2, where it was also predominantly associated
with granules (Fig. 2C). The OMA-1-GFP signal became
too weak to detect in the embryo after the four-cell stage.
The asymmetric segregation of OMA-1::GFP to the germ-
line precursors is characteristic of three other TIS11 germ-
line proteins: PIE-1, MEX-1, and POS-1 (Guedes and
Priess, 1997; Mello et al., 1996; Tabara et al., 1999). Our
ability to detect OMA-1 better in two-cell and four-cell
embryos by GFP versus antibody staining probably reflects
an increased sensitivity of detection with this method.
OMA-1 protein is not properly degraded in zu405 mutant
embryos
To understand the nature of the zu405 gain-of-function
mutation, we examined the expression of the OMA-1 and
OMA-2 proteins in oma-1(zu405) mutant embryos. By an-
tibody staining, we observed that, while OMA-2 protein
levels in oma-1(zu405) mutant embryos appeared normal
(data not shown), OMA-1 protein levels were elevated in
embryos past the 1-cell stage compared with wild type
embryos (Fig. 3). OMA-1 protein could be detected in more
than 80% of the zu405 embryos up to the 16-cell stage, in
contrast to wild-type embryos where OMA-1 antibody
staining was not detected in any 4- cell or older embryos.
Although the temporal regulation of OMA-1 protein is de-
fective in zu405 embryos, its spatial localization appeared to
be properly regulated. That is, the OMA-1 protein was still
detected primarily in the germline precursors in zu405 mu-
tant embryos. OMA-1 protein in zu405 mutant embryos is
both cytoplasmic and P-granule- associated. The P-granule
association of OMA-1 was confirmed by costaining with
various antibodies known to recognize P-granules, such as
OIC4, MEX-1 antibody, and POS-1 antibody (data not
shown). The persistence of OMA-1 protein in germline
precursors in oma-1(zu405) mutant embryos suggests that
sequences surrounding P240 are important for its rapid deg-
radation. P240 resides within a probable PEST domain, with
PESTfind (Rechsteiner and Rogers, 1996) giving a score of
9.7. PESTfind rates sequences from 50 to 50 with a
score of 5 or more signifying a probable PEST domain.
When P240 is mutated to leucine as in the oma-1(zu405)
mutant, the PESTfind score for the sequence immediately
surrounding this residue drops from 9.7 to 0.2.
oma-1(zu405) mutant embryos produce excess pharyngeal
and intestinal cells
To investigate why the oma-1(zu405) mutation results in
embryonic lethality, we first characterized its embryonic
lethal phenotype. oma-1(zu405) mutant embryos do not
undergo proper morphogenesis and arrest before hatching
with differentiated tissues, including intestinal, pharyngeal,
neuronal, skin, and muscle cells (Fig. 4, and data not
shown). The majority (75%) of oma-1(zu405) mutant em-
bryos have excess pharyngeal and intestinal tissues as de-
tected either by Nomarski optics or by staining with anti-
bodies specific to either tissue (Fig. 4). Many mutant
Fig. 2. Expression of the OMA-1 protein in embryos. (A) Fluorescence
micrographs of 1-cell (top panels) and 2-cell (bottom panel) wild type embryos
stained with affinity-purified OMA-1 antibody (left) and DAPI (right). A
similar pattern was obtained with OMA-2 antibody (data not shown). (B) A
montage of selected images from a movie recording of OMA-1::GFP from
one-cell to two-cell stage. Adjacent frames are recorded approximately 1 min
apart. Frame numbers are indicated at lower left corners. (C) OMA-1::GFP in
one-cell, two-cell, and four-cell embryos. Schematic representation of the
OMA-1::GFP is shown on the left-hand column, whereas the highly enhanced
GFP images are shown on the right-hand column. Shades of gray represent
different levels of GFP, with white being the brightest. The GFP signal shown
in two-cell and four-cell embryos is highly enhanced (compare frames 19 in B
and C). With the same scaling shown in (B), the signal in four-cell is not easily
detected. Arrowheads, germline precursors; asterisks, corresponding somatic
sisters. Short bars between cells indicate sister blastomeres. Bar, 10 m.
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embryos have up to 40 intestinal cells, twice the number
found in wild-type embryos. In most embryos observed, the
excess intestinal cells are well organized and are located at
the posterior–dorsal portion of the embryo parallel to the
endogenous intestine.
During wild-type embryogenesis, only one blastomere in
a 4-cell embryo, EMS, produces pharyngeal and intestinal
cells. When EMS is killed, no pharyngeal or intestinal cells
are produced (Priess and Thomson, 1987). We used a laser
microbeam to ablate EMS in 10 oma-1(zu405) embryos.
Eight of the operated embryos produced pharyngeal and
intestinal cells, suggesting that, in oma-1(zu405) embryos,
an additional blastomere or blastomeres adopts an EMS-like
fate. Because of the posterior location of the extra pharyn-
geal and intestinal tissues in oma-1(zu405) mutant embryos,
we asked whether these extra tissues are derived from the
posterior blastomere, P2, in 4-cell embryos. The fate of
individual blastomeres can be assayed by killing all other
blastomeres and allowing the partial embryo to develop in
isolation. In such experiments, wild-type EMS produces
pharyngeal muscles, body-wall muscles, and intestinal cells,
whereas wild-type P2 produces skin, body-wall muscles,
and 2 germ cells, corresponding to the fates of EMS and P2
in intact embryos, respectively (Mello et al., 1992). After
laser ablation of blastomeres in oma-1(zu405) embryos, an
isolated P2 blastomere produces pharyngeal muscles, body-
wall muscles, and intestinal cells, tissue types similar to
those normally produced by a wild-type EMS blastomere
(Table 1, and data not shown). This defect is reminiscent of
the phenotype observed for a previously described mutant,
pie-1, in which P2 adopts the fate of EMS and produces
EMS-derived tissues (Mello et al., 1992). However, unlike
pie-1 mutant embryos in which no germ cells are produced,
all oma-1(zu405) mutant embryos examined produced the
wild-type number of 2 germ cells (n  30; data not shown).
In wild-type embryos, germ cells are derived from one
daughter of P2, termed P3, and not the somatic sister blas-
tomere, C. The C blastomere normally produces skin and
muscle cells that are located at the posterior–dorsal portion
of the embryos. Because oma-1(zu405) mutant embryos
produced germ cells and often lacked skin and muscle cells
at the posterior–dorsal portion, we reasoned that the extra-
Fig. 4. oma-1(zu405) mutation results in excess pharyngeal and intestinal
muscle. Tissue differentiation in wild type (A, C, E) and oma-1(zu405)
mutant embryos (B, D, F) as shown by DIC images (A, B), and immuno-
fluorescence images with pharynx-specific antibody Mab3NB12 (C, D) or
intestine-specific antibody MabICB4 (E, F). Arrowheads in (F) point to a
focal plane where two intestinal lumens can be clearly recognized. Anterior
is to the left and dorsal is up. Bar, 10 m.
Fig. 3. The OMA-1 protein fails to degrade properly in oma-1(zu405)
mutant embryos. Immunofluorescence micrographs of various staged
oma-1 (zu405) mutant embryos stained with the affinity-purified antibody
to OMA-1 (left-hand column) and DAPI (right-hand column). Arrowheads,
germline precursors; asterisks, corresponding somatic sisters. Bar, 10 m.
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pharyngeal and intestinal tissues in oma-1(zu405) embryos
could be derived from a transformation of the C blastomere
to an EMS-like fate. We investigated this possibility by
ablating with a laser microbeam all blastomeres except the
C blastomere in zu405 embryos. In contrast to wild-type C
blastomeres, which produce skin and muscle in these ex-
periments, over half (56%, n  22) of C blastomeres from
oma-1(zu405) embryos produced either pharyngeal cells or
pharyngeal and intestinal cells (Table 1). Conversely, when
P3 was isolated in oma-1(zu405) embryos, we never ob-
served pharyngeal or intestinal tissues (data not shown).
These results suggest that, in oma-1(zu405) embryos, the C
blastomere adopts an EMS-like fate, resulting in extrapha-
ryngeal and intestinal tissues.
The C blastomere in the oma-1(zu405) mutant expresses
high levels of EMS transcription factor MED-1
and SKN-1
In wild-type embryos, production of the EMS-derived
pharyngeal and intestinal tissues requires four factors:
SKN-1, POS-1, MED-1, and MED-2 (Bowerman et al.,
1992; Maduro et al., 2001; Tabara et al., 1999). In the
absence of these factors, EMS adopts the fate of the C
blastomere and produces skin and muscle. SKN-1, MED-1,
and MED-2 are all transcription factors whose activities are
restricted to the EMS lineage (Bowerman et al., 1992, 1993;
Maduro et al., 2001). POS-1 is not expressed in EMS, and
its function in EMS fate remains unclear (Tabara et al.,
1999). We examined whether the C blastomere in oma-
1(zu405) embryos expresses any of these EMS factors and
whether this expression could account for the transforma-
tion to an EMS-like fate.
In wild-type embryos, SKN-1 protein is detected at high
levels in the nuclei of EMS and P2 but at low levels in the
four daughters of EMS and P2, the MS, E, C, and P3
blastomeres (Fig. 5B–D; Bowerman et al., 1993). In con-
trast, in oma-1(zu405) mutant embryos, the level of SKN-1
protein remains high in the daughters of EMS and P2 (18 of
19 embryos examined; Fig. 5F–H). In fact, the level of
SKN-1 protein in the C blastomere of oma-1(zu405) mutant
embryos is comparable with that in a wild-type EMS blas-
tomere. The level of SKN-1 protein decreases in the 12-
cell-stage oma-1(zu405) embryos and is not detectable after
the 12-cell stage. Generation of the extrapharyngeal and
intestinal tissues in zu405 mutant embryos requires SKN-1,
as RNAi of skn-1 in zu405 embryos results in embryos
without any pharyngeal tissues (data not shown). Approxi-
mately 30% (n  200) of the RNAi embryos still produce
intestinal tissues, consistent with the percentage of embryos
producing intestine in skn-1 null mutant embryos (Bower-
man et al., 1992).
Table 1
Tissue types produced by wild type and oma-1(zu405) partial embryos
Blastomeres
ablated
Wild type embryos oma-1(zu405) embryos
Pharynx and gut Pharynx, no gut No pharynx, no gut Pharynx and gut Pharynx, no gut No pharynx, no gut
EMS 0% (n  15) 0% (n  15) 100% (n  15) 80% (n  10) 20% (n  10) 0% (n  10)
All but P2 0% (n  13) 0% (n  13) 100%a (n  13) 100% (n  7) 0% (n  7) 0% (n  7)
All but C 0% (n  10) 0% (n  10) 100%a (n  10) 43.4% (n  22) 10.8% (n  22) 45.8%a (n  22)
All but EMS 100% (n  15) 0% (n  15) 0% (n  15) 73.9% (n  23) 26.1% (n  23) 0% (n  23)
a Partial embryos produce skin and muscles in these experiments.
Fig. 5. Delayed degradation of maternal SKN-1 protein in oma-1(zu405)
embryos. Fluorescence micrographs of wild-type (A–D) and oma-1(zu405)
mutant embryos (E–H) shown stained with SKN-1 antibodies. Embryonic
stages are indicated to the left. EMS, C, and P3 nuclei are indicated by
blastomere names. MS and E nuclei are at metaphase in (H) and have no
apparent nuclear SKN-1 staining. Note the high level of SKN-1 in the C
blastomere in (G). Bar, 10 m.
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MED-1 and MED-2 are functionally redundant, zygoti-
cally expressed GATA-like transcription factors. The ex-
pression of both proteins is dependent on SKN-1 and is
restricted to EMS and its descendants in wild-type embryos
(Maduro et al., 2001). It has been shown that ectopic ex-
pression of MED-1 is sufficient to induce EMS-derived cell
types from a non-EMS lineage (Maduro et al., 2001). A
Pmed-1gfp reporter construct expresses GFP exclusively in
MS and E, the daughters of EMS, and their descendants
(Fig. 6A–D; Maduro et al., 2001). When we introduced the
Pmed-1gfp reporter into oma- 1(zu405) mutant worms, we
consistently detected GFP in the descendants of the C blas-
tomere, Ca and Cp, in addition to EMS descendents (100%,
n  39; Fig. 6E–H). The intensity of MED-1::GFP in Ca
and Cp is never as bright as that in MS and E. These results
suggest that a high level of SKN-1 in the oma-1(zu405) C
blastomere induces the synthesis of MED-1 and an EMS-
like developmental fate. The persistence of maternal SKN-1
protein therefore would appear to be key to the C-to-EMS
fate transformation observed in oma-1(zu405) embryos.
C blastomere-derived intestine in oma-1(zu405), like wild-
type EMS blastomere-derived intestine, requires the Wnt
signaling component, WRM-1
In wild type C. elegans embryos, development of intes-
tine requires a Wnt-like signal at the four-cell stage from the
P2 blastomere to the EMS blastomere (Goldstein, 1992,
1993, 1995; Rocheleau et al., 1997; Thorpe et al., 1997). In
the absence of the P2 signal, the E blastomere develops like
its sister MS and produces pharyngeal and body-wall mus-
cles. In order to test whether the intestinal cells derived from
the C blastomere in oma-1(zu405) embryos also required a
Wnt-like signal, we removed one essential Wnt signaling
component, a -catenin homolog (WRM-1), via RNAi. In-
testinal cells are easily identified by their morphology under
differential interference contrast (DIC) optics as well as by
intestine-specific markers, the gut granules, which appear
birefringent under polarized light (Fig. 7A and B). When
WRM-1 was depleted by RNAi in wild-type animals, the
resulting embryos produced no intestinal cells, as observed
by the DIC image and by the lack of birefringent granules,
and produced excess pharyngeal tissues (Fig.7C and D;
Rocheleau et al., 1997). When wrm- 1(RNAi) was carried
out in oma-1(zu405) animals, intestinal tissues were also
completely eliminated (0%, n  50; Fig. 7E and F) and the
RNAi embryos instead also produced excess pharyngeal
tissues (Fig. 7E, and data not shown). These data suggest
that, like the E- derived intestinal tissue in wild-type em-
bryo, the ectopic, C-derived intestinal tissue in oma-
1(zu405) embryos required a Wnt signaling pathway.
P2-EMS signaling is defective in oma-1(zu405) mutant
embryos
Although the C blastomere is transformed to an EMS-
like fate in oma-1(zu405) embryos, this transformation is
not fully penetrant despite an almost complete defect in the
degradation of the SKN-1 and MED-1 proteins. Specifi-
cally, only 43% of the isolated C blastomeres from oma-
1(zu405) embryos generated gut and pharynx (Table 1).
Forty-six percent of the isolated C blastomeres from oma-
1(zu405) embryos generated skin and muscle similar to a
wild-type C blastomere. The remaining 11% of isolated C
blastomeres from oma-1(zu405) embryos generated only
pharyngeal tissue but no intestine, suggesting an EMS-like
transformation with defective induction of intestinal tissue
from the EMS-like blastomere.
To determine whether the partial penetrance of the fate
transformation of intestinal cells in zu405 embryos reflected
a general defect in Wnt-signaling, we examined whether
P2-to-EMS signaling is defective in zu405 mutant embryos.
In wild type embryos, P2-to-EMS signaling is responsible
for three easily scored properties of the wild type embryo:
Fig. 6. The C blastomere in oma-1(zu405) expresses an EMS-spe-
cific transcription factor MED-1. Fluorescence micrographs depicting
MED-1::GFP expression in 24-cell-stage wild-type (A–D) and oma-
1(zu405) mutant (E–H) embryos. Arrowheads in (A, B, E, F) point to 4
EMS descendents, whereas arrows in (C, D, G, H) indicate C descendents,
Ca and Cp, on a different focal plane. Bar, 10 m.
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First, endoderm is formed from the posterior daughter of
EMS, E (Goldstein, 1992, 1993, 1995; Rocheleau et al.,
1997; Thorpe et al., 1997). Second, nuclear levels of the
transcription factor POP-1 are lower in E than in MS
(Fig. 7G; Lin et al., 1998; Rocheleau et al., 1997; Thorpe et
al., 1997). Third, P2 to EMS signaling determines the divi-
sion axis of EMS parallel to the anterior–posterior axis of
the wild-type embryo. In a subset of mutants that are de-
fective in P2–EMS signaling, this EMS cleavage axis is
abnormal, often skewed to the left–right axis of the embryo
(Bei et al., 2002; Schlesinger et al., 1999).
We assessed these three aspects of embryonic develop-
ment in oma-1(zu405) mutant embryos. We found that, in
contrast to wild-type embryos, 26% of EMS blastomeres of
oma-1(zu405) embryos isolated by laser ablation did not
produce intestinal cells but instead produced excess pharyn-
geal and body-wall muscles (Table 1). Second, in oma-
1(zu405) mutant embryos, 30% (n 20) of the embryos had
symmetric levels of POP-1 protein in the daughters of EMS
as assessed by staining with a monoclonal antibody
(mabRL1) that detects POP-1 protein (Fig. 7H). Third, 50%
of oma-1(zu405) embryos examined (n  38) had a cleav-
age axis rotated at least 60° relative to the a-p axis. These
data suggest that the EMS blastomeres of oma- 1(zu405)
embryos have defects consistent with abnormalities in the
Wnt signaling pathways that normally determine EMS
fate.
Regulated degradation of several maternal proteins is
defective in oma-1(zu405) mutant embryos
Although the production of ectopic intestinal and pha-
ryngeal tissues in oma- 1(zu405) mutant embryos can be
attributed to the delayed degradation of the SKN-1 tran-
scription factor (see above), it is not clear why SKN-1
degradation should be delayed or why P2-to-EMS signaling
is partially defective in oma-1(zu405) mutant embryos. By
examining the expression patterns of several other maternal
factors, we have observed a more general effect of the
oma-1(zu405) mutation on the degradation of these pro-
teins. In particular, protein degradation in the somatic blas-
tomeres appears delayed.
In wild-type embryos, the PIE-1 protein is segregated to
the germline precursor (Fig. 8A and B; Mello et al., 1996).
The asymmetric localization of PIE-1 protein is regulated
by two distinct mechanisms: asymmetric enrichment toward
the future germline precursor cell prior to cell division and
selective degradation of PIE-1 in the somatic sister cells
(Reese et al., 2000). In oma-1(zu405) mutant embryos car-
rying a Ppie-1gfp reporter construct, PIE-1::GFP is preferen-
tially segregated to the germline precursors, as in wild-type
embryos, but, in contrast to wild type embryos, higher than
normal levels of GFP are observed in the somatic sisters
(Fig. 8C and D). The asymmetric enrichment of PIE-1::GFP
toward the future germline precursor cell prior to cell divi-
sion was clearly observed in oma-1(zu405) mutants (data
not shown), suggesting that degradation of PIE- 1::GFP in
the somatic sisters is abnormal in these embryos. To test
whether the persistence of PIE-1::GFP in the somatic sister
cells might reflect a more general defect in the degradation
of germline proteins, we examined segregation of the
MEX-1 and POS-1 proteins in zu405 mutant embryos. We
observed a similar but less severe persistence of MEX-1 and
POS-1 proteins in somatic cells in oma-1(zu405) embryos
by antibody staining (Fig. 8E–L).
The delay in degradation of maternal proteins in oma-
1(zu405) mutant embryos was not a germline protein-spe-
cific phenomenon because it was also observed for two
other maternal proteins not specifically localized to the
germline precursors, MEX-5 and MEX-3. MEX-5 is a
TIS11 zinc finger protein expressed in a pattern opposite to
germline proteins: it is expressed for approximately one cell
cycle in the somatic daughter after each division of the
germline precursors (Fig. 8M and N; Schubert et al., 2000).
For example, MEX-5 is detected in wild-type four-cell
Fig. 7. Wnt signaling and endoderm formation in wild type and oma-
1(zu405) mutant embryos. (A–F) Endoderm differentiation in wild type (A,
B), wrm-1(RNAi) (C, D), and oma- 1(zu405);wrm-1(RNAi) (E, F) embryos.
Endoderm differentiation is shown as DIC images (A, C, E) and viewed
with polarized microscopy as birefringent granules (B, D, F). (G, H)
Immunofluorescence micrographs of eight-cell-staged wild type (G) and
oma- 1(zu405) (H) embryos stained with mabRL2, a monoclonal antibody
to POP-1. Each doubleheaded arrow points to an MS nucleus (left) and an
E nucleus (right). Bar, 10 m.
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embryos in EMS, the somatic sister of the germline precur-
sor cell P2, and in eight-cell embryos in C, the somatic sister
of P3. As for wild type embryos, antibody staining of
oma-1(zu405) embryos detects MEX- 5 in EMS and C, the
somatic sister cells of the P2 and P3 germline precursors,
respectively. However, in contrast to wild type embryos, the
MEX-5 protein could be detected in the progeny generated
by EMS and C for at least one further cell cycle compared
with wild type. As a result, we consistently detected MEX-5
protein in multiple somatic cells (Fig. 8O and P).
We obtained similar results for the MEX-3 protein. In
wild type 2-cell embryos, the protein MEX-3 has been
shown to localize to the cytoplasm of the anterior cell, AB,
and to be associated with P-granules in P1 (Draper et al.,
1996). In 4-cell embryos, MEX-3 localizes to the cytoplasm
of the daughters of AB and is associated with P- granules in
P2. By the 8-cell stage, MEX-3 protein is no longer detected
(Fig. 8Q and R). In oma-1(zu405) embryos, we consistently
detected a significant level of cytoplasmic MEX-3 protein in
the descendants of AB blastomeres and P-granule-associ-
ated MEX-3 in the germline precursor in 8-cell-and 12-cell-
stage embryos (Fig.8S and T). For both MEX-5 and
Fig. 8. Delayed degradation of several maternal proteins in oma-1(zu405) mutant embryos. Expression of PIE-1 (A–D), POS-1 (E–H), MEX-1 (I–L), MEX-5
(M–P), and MEX-3 (Q–T) in wild-type (A–B, E–F, I–J, M–N) and oma-1(zu405) mutant (C–D, G–H, K–L, O–P) embryos. The expression of PIE-1 protein
is assayed using PIE-1::GFP (A, C), and the stage of embryos is shown with DIC images (B, D). Expression of all other proteins is shown by
immunofluorescence using specific antibodies. (E, G, I, K, M, O, Q, S) Immunofluorescence micrographs; (F, H, J, L, N, P, R, T) DAPI staining. For each
protein, the embryos shown for wild type and the oma-1(zu405) mutant are at a comparable stage. Germline blastomeres are indicated with arrowheads. The
germline nucleus in the embryo shown in (O) and (P) is not visible on this focal plane. The exposure is the same for wild-type and oma-1(zu405) embryos
with each antibody. Note that the delayed degradation of MEX-1 and POS-1 is not as dramatic as seen with the other proteins and the photographs have been
purposely enhanced to demonstrate this point. Bar, 10 m.
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MEX-3, it appears that their synthesis, both temporally and
spatially, is properly regulated but their degradation is de-
layed. These observations suggest that the early degradation
of the OMA-1 protein in the embryo somehow contributes
to the later degradation of several other maternal regulators
in the fate specification of early blastomeres (see Discus-
sion).
Discussion
We describe here a novel embryonic lethal phenotype
resulting from misregulated degradation of OMA-1 protein
in the gain-of-function oma-1(zu405) mutant. Wild-type
OMA-1 protein is expressed at a very high level in the
newly fertilized embryo. After the first mitotic division,
OMA-1 is degraded rapidly and the remaining protein is
preferentially segregated into the germline precursor cell.
Degradation of OMA-1 and several other maternally sup-
plied proteins, including SKN-1, PIE-1, MEX-1, POS-1,
MEX-3, and MEX-5, is delayed in oma-1(zu405) mutants,
suggesting that this allele of oma-1 interferes with degra-
dation of these early embryonic cell fates determinants.
oma-1(zu405) mutant embryos have extra pharynx and in-
testinal cells, and we show that these defects are a result of
abnormally high levels of the SKN-1 protein in the C
blastomere and transformation of the C blastomere to an
EMS-like fate.
Defect in the degradation of maternally supplied proteins
in oma-1(zu405) mutant embryos
We show that several maternally supplied proteins,
SKN-1, PIE-1, MEX-5, MEX-3, and likely POS-1 and
MEX-1 as well, are all detectable at later stages in oma-
1(zu405) embryos than they are normally detected in wild
type embryos. These observations suggest that somehow the
prolonged elevation of OMA-1 protein in zu405 embryos
allows the persistence of these maternal proteins. Because
the CCCH TIS11 zinc finger protein has been implicated in
mRNA binding (Bai and Tolias, 1996; Barabino et al.,
1997; Lai et al., 1999), it is possible that OMA-1 protein in
zu405 embryos directly interferes with the degradation of
mRNAs for these maternal proteins. These transcripts are
Class II maternal mRNAs characterized by distribution
throughout the early blastomeres but degraded progres-
sively in the somatic cells after the four-cell stage (Draper et
al., 1996; Guedes and Priess, 1997; Mello et al., 1996;
Seydoux and Fire, 1994; Tabara et al., 1999). Interference
with the degradation of Class II maternal mRNAs could
result in the observed persistence of corresponding maternal
proteins in somatic cells after the four-cell stage. However,
it has been shown that the amino acid, and not nucleic acid,
sequence is responsible for the degradation of PIE-1,
MEX-1, and POS-1 proteins in somatic sisters (Reese et al.,
2000). This result makes the above scenario unlikely, and
instead suggests that OMA-1 protein in zu405 embryos may
result in the persistence of maternal proteins by interfering
with protein degradation.
How, then, would the persistence of OMA-1 protein in
germline precursors interfere with the degradation of ma-
ternal proteins in somatic cells? It is especially puzzling for
a protein such as MEX-5 that is expressed exclusively in
nongermline cells. One possible explanation is that, in wild-
type embryos, the degradation of proteins in somatic cells
requires an activity from the germline precursor (see next
section for more detail). In each division of the germline
precursor, some of the activity is segregated to the somatic
sister. The overabundance of OMA-1 protein in germline
precursors in zu405 embryos somehow interferes with this
segregation process.
The potential function of OMA-1 and OMA-2 in embryo
development
The identical localization pattern of OMA-1 and OMA-2
proteins and their redundant function in oocyte maturation
suggest a redundant function for these two proteins in early
embryo development. Unfortunately, oma-1;oma-2 mutant
animals are sterile (Detwiler et al., 2001), which makes it
technically difficult to address their function in embryos. It
is conceivable that neither OMA-1 nor OMA-2 has any
function in wild- type embryos. The observed phenotype in
zu405 embryos could be due to a neomorphic OMA-1
protein with a novel activity. Alternatively, the overabun-
dance of OMA-1 protein in the germline blastomere could
saturate the degradation machinery that normally degrades
maternal proteins. We do not believe this to be likely be-
cause wild- type embryos overexpressing germline proteins,
such as PIE-1, MEX-1, and POS-1, undergo normal embry-
ogenesis (Reese et al., 2000).
Assuming that the zu405 phenotype is the result of an
overabundance of OMA-1 protein performing its normal
function, we suggest the following function for OMA-1 and
OMA-2 in wild-type embryos. We propose that OMA-1 and
OMA-2 are present at high levels in newly fertilized em-
bryos to prevent premature activation of a protease activity
(or activities) responsible for the degradation of many ma-
ternal proteins. As some TIS11 proteins have been impli-
cated in RNA binding, this interference could be via binding
to the mRNA encoding a protease component, thereby pre-
venting its synthesis. After the first embryonic division, the
majority of OMA-1 and OMA-2 is degraded, releasing the
mRNA and allowing the initiation of protease synthesis.
The protease activity is predominantly in the somatic cell,
AB, as the protease mRNA segregated to the P1 blastomere
remains bound and inactivated by the residual OMA-1 and
OMA-2. When P1 divides, the further degradation of
OMA-1 and OMA-2 and the asymmetric segregation of the
remaining OMA proteins to the P2 blastomere allow the
synthesis of more protease(s) in the somatic sister of P2,
EMS. The same pattern reiterates in each division of a
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germline blastomere, allowing the sequential synthesis of a
protease(s) in somatic sisters.
In contrast to wild-type embryos, in oma-1(zu405) mu-
tant embryos where the level of OMA-1 protein remains
high in P1 after the first division, a higher portion of mRNA
remains bound to the residual OMA-1 protein in P1 and a
corresponding smaller amount of protease mRNA is re-
leased and translated in the somatic sister AB. In each of the
following germline blastomere division, compared with
wild-type embryos, a smaller amount of protease mRNA is
released to the somatic sister. Therefore, in zu405 embryos,
the protease activity is lower in somatic cells, leading to the
observed delayed degradation of maternal proteins.
Rescue the gain-of-function mutation
Assuming the zu405 phenotype is the result of an over-
abundance of OMA-1 protein performing its normal func-
tion, it is somewhat counterintuitive as to why the embry-
onic lethality of oma-1(zu405) could be weakly rescued by
a wild-type oma-1 gene (see Materials and methods). This
rescue result can be explained by a process known as co-
suppression. Cosuppression was first described in plants and
referred to the silencing of the endogenous gene triggered
by the introduction of transgenic DNA (Matzke and Matzke,
1995). Because oma-1 null mutant worms are viable and
produce live progeny (Detwiler et al., 2001), silencing of the
endogenous, mutant oma-1 gene should therefore suppress
the embryonic lethality of zu405. Cosuppression of the
endogenous, mutant oma-1 gene by oma-1 transgenes has
recently also been observed by Rosa Alcazar and Andrew
Fire (personal communication).
C-to-EMS fate transformation
The C blastomere in oma-1(zu405) mutant embryos not
only produces EMS- derived tissue types, but also exhibits
other EMS-specific properties, including expression of the
MED-1 transcription factor and dependence on the wrm-1
activity to produce intestine.
In wild-type embryos, the level of SKN-1 protein is high
in both the EMS and P2 blastomeres but remains inactive in
P2 due to the presence of the germline-specific repressor
protein PIE-1 (Bowerman et al., 1993; Mello et al., 1992).
When P2 divides, the C blastomere inherits SKN-1 and,
although not inheriting PIE-1, does not produce SKN-1-
dependent tissues. This lack of SKN-1-dependent tissues
from the wild-type C blastomere has been attributed to
insufficient levels of SKN-1 protein in C at the eight- cell
stage (Hunter and Kenyon, 1996). We observed that the C
blastomere in oma- 1(zu405) mutant embryos contained a
higher than wild-type level of SKN-1 protein and produced
EMS-derived tissues. These data strongly support the model
that the difference in fate specification between wild-type
EMS and C is primarily a result of SKN-1 protein level
differences between these two blastomeres.
Although we have shown that a P2–EMS Wnt-signaling
component is required for intestine formation from the C
blastomere in oma-1(zu405) embryos, it is currently not
clear whether a signaling cell is required. It has been shown
previously that an isolated P2 blastomere retains its capa-
bility to polarize EMS even after it divides into P3 and C
(Goldstein, 1995). However, it has not been determined
whether one, or both, of the P2 daughters inherit this sig-
naling ability. If a signaling cell is required for oma-
1(zu405) C blastomere to produce intestine, a highly likely
candidate is the germline precursor P3.
Defect in P2-to-EMS signaling
In two other C. elegans mutants, gsk-3 and src-1, intes-
tinal cells are generated from the C blastomere (Bei et al.,
2002; Maduro et al., 2001; Schlesinger et al., 1999). Al-
though the oma-1(zu405) phenotype bears some similarity
to these mutants, oma- 1(zu405) also has characteristics that
distinguish it from gsk-3 and src-1. gsk-3 and src-1 are
similar to zu405 in that: (1) mutant embryos exhibit partially
penetrant defects in P2- to-EMS signaling; (2) some per-
centage of C blastomeres in these mutants generate intestine
rather than skin and muscle; and (3) the EMS division axis
is rotated with respect to the embryonic A-P axis. However,
unlike oma-1(zu405), the C blastomeres from gsk-3 or src-1
mutant embryos do not produce MS-derived tissues, and it
is this characteristic that uniquely defines the oma-1(zu405)
phenotype.
It is currently not clear why oma-1(zu405) mutant em-
bryos exhibit defects in P2- to-EMS signaling. Given our
observations that oma-1(zu405) mutant embryos have de-
fects in the degradation of several proteins, one possible
explanation is that proper protein degradation plays a role in
C. elegans P2-to-EMS signaling. Alternatively, it is possi-
ble that the oma-1(zu405) phenotype is due to an indirect
result of inactivation of GSK-3 or SRC-1 proteins.
Oocyte maturation and early embryonic events
In vertebrates, oocytes undergo maturation before arrest-
ing in metaphase II, at which point they can be fertilized by
sperm. Activation of protein and DNA synthesis occurs
within several minutes of fertilization and is brought about
by an increase in the intracellular Ca2 concentration and
pH (see review by Ben-Yosef and Shalgi, 1998). A high
level of Ca2 mediates the degradation of cyclin B and
consequent inactivation of MPF (maturation promoting fac-
tor) and CSF (cytostatic factor) upon fertilization of Xeno-
pus embryos, allowing entry into the first mitotic cycle
(Lorca et al., 1993). In an animal like C. elegans, where all
factors required for early embryonic development come
packaged in the egg and no delay between oocyte matura-
tion and fertilization is apparent, oocyte maturation, fertil-
ization, and initiation of embryogenesis must be tightly
coordinated. Such coordination might include turnover or
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inactivation of oocyte-specific proteins and the synthesis or
activation of zygote-specific proteins important for early
embryonic development. One attractive model for the co-
ordinated regulation of these two processes would be for the
activation of zygote-specific proteins to be contingent on the
degradation of a key regulator of oocyte maturation. The
interesting expression pattern of OMA proteins and the
oma-1(zu405) gain-of-function phenotype suggest the in-
triguing model that OMA-1 and OMA-2 coordinate oocyte
maturation with early embryonic events in C. elegans. Fur-
ther efforts are underway to investigate this model.
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